Giorgio Parmiani obtained his MD degree at School of Medicine of the University of Milan in 1967. Then he specialized in Oncology at University of Pavia in 1973.

He is currently Head of the Unit of Immunotherapy of Human Tumors and Director of the Department of Innovative Therapy of the Istituto Nazionale Tumori (INT) of Milan. Professor Parmiani was trained in tumor immunology at the Institute for Cancer Research of Philadelphia and then has continued his career at the INT. Since 1996 he is Professor of Oncology (contract) at the School of Oncology of the University of Milan. He has been actively involved in pre-clinical and translational research in tumor immunology and immunotherapy. His main interests are focused on human tumor antigens, T cell response, escape mechanisms and immunotherapy of human tumors. He is in the editorial board of several scientific journals and has served and continues to serve as reviewer in the major oncology and immunology journals.

Professor Parmiani is author and co-author of over 400 publications most in international peer-reviewed journals, and of 38 book chapters.